Belly fat graft for recurrent brain tumor
Part of Brain & nervous system, Cancer clinical trials.
This study tests if a piece of your own belly fat (omentum) placed in the brain during tumor surgery can help fight recurrent glioblastoma. It is for people who are already scheduled for surgery to remove their brain tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have recurrent glioblastoma (a brain tumor that has come back), and your surgeon plans to remove at least 80% of it.
- You are generally healthy enough for surgery (able to care for yourself, life expectancy at least 6 months).
- You have no active infections, uncontrolled other cancers, or conditions that make MRI unsafe.
- You have not had prior abdominal surgery that would make the omentum (a layer of fat in your belly) hard to use for the graft.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a surgical technique that places a tissue flap near a glioblastoma surgery site to help medicines reach the brain more effectively. You might be considered if you are planning major brain tumor surgery and meet specific health, imaging, and lab requirements.
This study uses special PET scans (fluciclovine and FDG) and advanced MRI to create a detailed metabolic profile of glioblastoma. It may help doctors better understand your tumor before surgery.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This study aims to improve understanding of glioblastoma (and gliosarcoma) by preserving live, usable brain-tissue samples during brain surgery. If you’re having repeat tumor surgery or your scans suggest these cancers, the study may ask to collect tissue for research.
This early-stage trial tests whether a new oral medication called gallium maltolate can help slow or shrink glioblastoma (a serious brain tumor) that has come back after initial treatment. The study enrolls patients who have already had standard brain tumor treatment and whose tumors are growing again.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.